Ingevity Stock Price, News & Analysis (NYSE:NGVT)

$70.56 0.44 (0.63 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$70.56
Today's Range$70.23 - $71.78
52-Week Range$51.01 - $80.18
Volume521,728 shs
Average Volume289,280 shs
Market Capitalization$2.95 billion
P/E Ratio28.39
Dividend YieldN/A
Beta1.78

About Ingevity (NYSE:NGVT)

Ingevity logoIngevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals. The Performance Materials segment primarily produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Performance Chemicals segment develops, manufactures and sells a range of specialty chemicals primarily derived from co-products of the Kraft pulping process. Its products are used in a range of applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, publication inks and automotive components that reduce gasoline vapor emissions.

Receive NGVT News and Ratings via Email

Sign-up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Commodity Chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:NGVT
CUSIPN/A
Phone843-740-2300

Debt

Debt-to-Equity Ratio1.92%
Current Ratio2.36%
Quick Ratio1.34%

Price-To-Earnings

Trailing P/E Ratio28.39
Forward P/E Ratio28.34
P/E Growth2.34

Sales & Book Value

Annual Sales$908.30 million
Price / Sales3.27
Cash Flow$3.03 per share
Price / Cash23.29
Book Value$3.20 per share
Price / Book22.05

Profitability

Trailing EPS$2.22
Net Income$35.20 million
Net Margins9.86%
Return on Equity58.14%
Return on Assets12.09%

Miscellaneous

Employees1,500
Outstanding Shares42,120,000

Ingevity (NYSE:NGVT) Frequently Asked Questions

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

How were Ingevity's earnings last quarter?

Ingevity Corporation (NYSE:NGVT) posted its earnings results on Wednesday, November, 1st. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.75 by $0.11. The firm had revenue of $264.10 million for the quarter, compared to analyst estimates of $260.88 million. Ingevity had a return on equity of 58.14% and a net margin of 9.86%. Ingevity's revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.64 earnings per share. View Ingevity's Earnings History.

When will Ingevity make its next earnings announcement?

Ingevity is scheduled to release their next quarterly earnings announcement on Wednesday, February, 28th 2018. View Earnings Estimates for Ingevity.

Where is Ingevity's stock going? Where will Ingevity's stock price be in 2017?

5 brokerages have issued 12 month target prices for Ingevity's stock. Their forecasts range from $67.00 to $90.00. On average, they expect Ingevity's stock price to reach $79.20 in the next year. View Analyst Ratings for Ingevity.

What are Wall Street analysts saying about Ingevity stock?

Here are some recent quotes from research analysts about Ingevity stock:

  • 1. According to Zacks Investment Research, "Ingevity Corporation provides specialty chemicals, carbon materials and technologies. The Company's operating segments consists of Performance Materials and Performance Chemicals. Performance Chemicals segment products consists of asphalt paving, adhesives, agrochemical dispersants, printing inks, lubricants, petroleum and other diverse industries. Performance Materials segment engineers, manufactures and sells wood-based chemically activated carbon products. Ingevity Corporation is based in North Charleston, SC. " (10/4/2017)
  • 2. Jefferies Group LLC analysts commented, "The introduction of a tighter fuel vapor emission standard by the European Union, and the likely tightening of standards in China, should accelerate activated carbon in 2019-2020. Near-term, the US shift to a near-zero standard will support Performance Materials revenue. Industrial specialties pricing remains weak, but a rebound in energy sales and strength in pavement technologies should support Performance Chemicals sales. Q4 results: Q4 EPS of $0.34 was $0.04 above consensus but $0.02 below our projections." (2/25/2017)

Who are some of Ingevity's key competitors?

Who are Ingevity's key executives?

Ingevity's management team includes the folowing people:

  • Richard B. Kelson, Independent Chairman of the Board (Age 70)
  • D. Michael Wilson, President, Chief Executive Officer, Director (Age 54)
  • John C. Fortson, Chief Financial Officer, Executive Vice President, Treasurer (Age 49)
  • Katherine Pryor Burgeson J.D., Executive Vice President, General Counsel, Secretary (Age 59)
  • Michael P, Smith, Executive Vice President and President, Performance Chemicals, Strategy and Business Development (Age 56)
  • S. Edward Woodcock Jr., Senior Vice President and President of Performance Materials (Age 51)
  • Dan Gallagher, Vice President, Financial Planning & Analysis and Investor Relations
  • Jean S. Blackwell, Independent Director (Age 62)
  • Luis Fernandez-Moreno, Independent Director (Age 54)
  • J. Michael Fitzpatrick, Independent Director (Age 70)

Who owns Ingevity stock?

Ingevity's stock is owned by many different of retail and institutional investors. Top institutional investors include Channing Capital Management LLC (2.21%), Bank of New York Mellon Corp (1.62%), Cortina Asset Management LLC (1.15%), American Century Companies Inc. (1.04%), Dimensional Fund Advisors LP (0.98%) and Wells Fargo & Company MN (0.86%). View Institutional Ownership Trends for Ingevity.

Who sold Ingevity stock? Who is selling Ingevity stock?

Ingevity's stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., DSAM Partners London Ltd, GSA Capital Partners LLP, Mesirow Financial Investment Management Equity Management, Axiom International Investors LLC DE, California State Teachers Retirement System, Cortina Asset Management LLC and Boothbay Fund Management LLC. View Insider Buying and Selling for Ingevity.

Who bought Ingevity stock? Who is buying Ingevity stock?

Ingevity's stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Patten Group Inc., Prudential Financial Inc., Rice Hall James & Associates LLC, Segall Bryant & Hamill LLC, ClariVest Asset Management LLC, Convergence Investment Partners LLC and Wells Fargo & Company MN. View Insider Buying and Selling for Ingevity.

How do I buy Ingevity stock?

Shares of Ingevity can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ingevity's stock price today?

One share of Ingevity stock can currently be purchased for approximately $70.56.

How big of a company is Ingevity?

Ingevity has a market capitalization of $2.95 billion and generates $908.30 million in revenue each year. The company earns $35.20 million in net income (profit) each year or $2.22 on an earnings per share basis. Ingevity employs 1,500 workers across the globe.

How can I contact Ingevity?

Ingevity's mailing address is 5255 VIRGINIA AVENUE, NORTH CHARLESTON SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]


MarketBeat Community Rating for Ingevity (NGVT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  99 (Vote Outperform)
Underperform Votes:  87 (Vote Underperform)
Total Votes:  186
MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Ingevity (NYSE:NGVT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.882.882.862.86
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $76.00$68.33$62.40$56.40
Price Target Upside: 3.02% downside8.49% downside1.05% upside5.05% downside

Ingevity (NYSE:NGVT) Consensus Price Target History

Price Target History for Ingevity (NYSE:NGVT)

Ingevity (NYSE:NGVT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/30/2017RoweReiterated RatingOutperform$80.00 -> $90.00MediumView Rating Details
11/14/2017Loop CapitalReiterated RatingBuy$76.00 -> $80.00N/AView Rating Details
11/3/2017Jefferies GroupBoost Price TargetBuy$71.00 -> $84.00N/AView Rating Details
10/5/2017KeyCorpReiterated RatingBuy$70.00 -> $75.00N/AView Rating Details
7/4/2017AegisReiterated RatingBuy$67.00LowView Rating Details
12/15/2016OppenheimerReiterated RatingOutperform$50.00 -> $60.00N/AView Rating Details
9/23/2016Buckingham ResearchInitiated CoverageNeutralN/AView Rating Details
8/6/2016SunTrust BanksReiterated RatingBuyN/AView Rating Details
6/10/2016BB&TInitiated CoverageBuy$44.00N/AView Rating Details
(Data available from 12/16/2015 forward)

Earnings

Ingevity (NYSE:NGVT) Earnings History and Estimates Chart

Earnings by Quarter for Ingevity (NYSE:NGVT)

Ingevity (NYSE NGVT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2018        
11/1/2017Q3 2017$0.75$0.86$260.88 million$264.10 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.70$0.78$259.56 million$260.30 millionViewN/AView Earnings Details
5/3/2017Q1 2017$0.47$0.49$206.90 million$218.50 millionViewListenView Earnings Details
2/22/2017Q416$0.30$0.34$201.96 million$210.90 millionViewN/AView Earnings Details
11/2/2016Q316$0.61$0.64$247.60 million$252.00 millionViewN/AView Earnings Details
8/3/2016Q216$0.49$0.66$246.70 million$248.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Ingevity (NYSE:NGVT) Earnings Estimates

Current Year EPS Consensus Estimate: $2.49 EPS
Next Year EPS Consensus Estimate: $2.9 EPS

Dividends

Dividend History for Ingevity (NYSE:NGVT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Ingevity (NYSE NGVT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.06%
Institutional Ownership Percentage: 91.41%
Insider Trades by Quarter for Ingevity (NYSE:NGVT)
Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Ingevity (NYSE NGVT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2017Jean S BlackwellDirectorBuy1,500$58.38$87,570.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Ingevity (NYSE NGVT) News Headlines

Source:
DateHeadline
Ingevity (NGVT) & Its Rivals Head to Head AnalysisIngevity (NGVT) & Its Rivals Head to Head Analysis
www.americanbankingnews.com - December 15 at 5:26 PM
Contrasting Ingevity (NGVT) & Its PeersContrasting Ingevity (NGVT) & Its Peers
www.americanbankingnews.com - December 15 at 3:30 PM
Ingevity Corp. – Value Analysis (NYSE:NGVT) : December 14, 2017Ingevity Corp. – Value Analysis (NYSE:NGVT) : December 14, 2017
finance.yahoo.com - December 14 at 6:00 PM
Contrasting Ingevity (NGVT) & The CompetitionContrasting Ingevity (NGVT) & The Competition
www.americanbankingnews.com - December 14 at 1:30 PM
Ingevity (NGVT) vs. Its Competitors Head to Head AnalysisIngevity (NGVT) vs. Its Competitors Head to Head Analysis
www.americanbankingnews.com - December 13 at 7:24 PM
Ingevity Corp. breached its 50 day moving average in a Bearish Manner : NGVT-US : December 13, 2017Ingevity Corp. breached its 50 day moving average in a Bearish Manner : NGVT-US : December 13, 2017
finance.yahoo.com - December 13 at 8:46 AM
Innophos (IPHS) and Ingevity (NGVT) Head to Head SurveyInnophos (IPHS) and Ingevity (NGVT) Head to Head Survey
www.americanbankingnews.com - December 11 at 9:30 PM
Ingevity Corporation (NGVT) Expected to Announce Quarterly Sales of $210.65 MillionIngevity Corporation (NGVT) Expected to Announce Quarterly Sales of $210.65 Million
www.americanbankingnews.com - December 11 at 10:58 AM
Analyzing Ingevity (NGVT) and Its PeersAnalyzing Ingevity (NGVT) and Its Peers
www.americanbankingnews.com - December 8 at 5:36 AM
Comparing Ingevity (NGVT) and Its PeersComparing Ingevity (NGVT) and Its Peers
www.americanbankingnews.com - December 7 at 11:34 AM
Comparing Enzymotec (ENZY) & Ingevity (NGVT)Comparing Enzymotec (ENZY) & Ingevity (NGVT)
www.americanbankingnews.com - December 7 at 1:24 AM
Contrasting Ingevity (NGVT) & CSW Industrials (CSWI)Contrasting Ingevity (NGVT) & CSW Industrials (CSWI)
www.americanbankingnews.com - December 6 at 2:46 PM
Ingevity (NGVT) vs. Its Competitors Head to Head ReviewIngevity (NGVT) vs. Its Competitors Head to Head Review
www.americanbankingnews.com - December 6 at 3:12 AM
CF Industries (CF) Subsidiary Redeems Senior Notes Due 2018CF Industries (CF) Subsidiary Redeems Senior Notes Due 2018
www.zacks.com - December 4 at 8:30 AM
Ingevity (NGVT) versus NewMarket (NEU) Financial ContrastIngevity (NGVT) versus NewMarket (NEU) Financial Contrast
www.americanbankingnews.com - December 3 at 5:30 PM
Reviewing Quaker Chemical (KWR) & Ingevity (NGVT)Reviewing Quaker Chemical (KWR) & Ingevity (NGVT)
www.americanbankingnews.com - December 3 at 11:44 AM
Contrasting Ingevity (NGVT) and Westlake Chemical Partners (WLKP)Contrasting Ingevity (NGVT) and Westlake Chemical Partners (WLKP)
www.americanbankingnews.com - December 3 at 9:56 AM
Reviewing Ingevity (NGVT) and Its PeersReviewing Ingevity (NGVT) and Its Peers
www.americanbankingnews.com - December 2 at 8:46 AM
Head to Head Review: Ingevity (NGVT) & Its PeersHead to Head Review: Ingevity (NGVT) & Its Peers
www.americanbankingnews.com - November 30 at 9:32 PM
Rowe Reaffirms Outperform Rating for Ingevity (NGVT)Rowe Reaffirms Outperform Rating for Ingevity (NGVT)
www.americanbankingnews.com - November 30 at 9:51 AM
Ingevity to open new automotive testing center in Zhuhai, ChinaIngevity to open new automotive testing center in Zhuhai, China
finance.yahoo.com - November 30 at 9:31 AM
Celanese (CE) Set to Raise Acetaldehyde Price in EuropeCelanese (CE) Set to Raise Acetaldehyde Price in Europe
finance.yahoo.com - November 30 at 8:39 AM
NGVT Crosses Above Average Analyst TargetNGVT Crosses Above Average Analyst Target
www.nasdaq.com - November 29 at 6:29 PM
Eastman Chemical Tritan Picked for Panasonic Food ProcessorsEastman Chemical Tritan Picked for Panasonic Food Processors
finance.yahoo.com - November 29 at 8:28 AM
Kraton Corp (KRA) Up 46% in 3 Months: Whats Driving It?Kraton Corp (KRA) Up 46% in 3 Months: What's Driving It?
www.msn.com - November 28 at 10:20 AM
Celanese (CE) Shares Up 36% YTD: Whats Driving the Stock?Celanese (CE) Shares Up 36% YTD: What's Driving the Stock?
finance.yahoo.com - November 28 at 10:20 AM
Ingevity (NGVT) vs. Its Rivals Financial ReviewIngevity (NGVT) vs. Its Rivals Financial Review
www.americanbankingnews.com - November 25 at 11:04 PM
Ingevitys (NGVT) "Buy" Rating Reiterated at Loop CapitalIngevity's (NGVT) "Buy" Rating Reiterated at Loop Capital
www.americanbankingnews.com - November 25 at 4:12 PM
Innospec (IOSP) Up 27% in 3 Months: Whats Driving It?Innospec (IOSP) Up 27% in 3 Months: What's Driving It?
finance.yahoo.com - November 24 at 9:25 AM
Agrium Poised on Retail Expansion Amid Pricing ConcernsAgrium Poised on Retail Expansion Amid Pricing Concerns
www.zacks.com - November 24 at 9:25 AM
Zacks: Brokerages Expect Ingevity Corporation (NGVT) Will Post Quarterly Sales of $210.65 MillionZacks: Brokerages Expect Ingevity Corporation (NGVT) Will Post Quarterly Sales of $210.65 Million
www.americanbankingnews.com - November 23 at 8:32 AM
AK Steel Poised on Strategic Actions Amid Pricing PressureAK Steel Poised on Strategic Actions Amid Pricing Pressure
www.zacks.com - November 23 at 6:51 AM
Ingevity Corporation (NGVT) Given Average Recommendation of "Buy" by AnalystsIngevity Corporation (NGVT) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - November 22 at 1:34 AM
 Brokerages Anticipate Ingevity Corporation (NGVT) Will Post Earnings of $0.36 Per Share Brokerages Anticipate Ingevity Corporation (NGVT) Will Post Earnings of $0.36 Per Share
www.americanbankingnews.com - November 21 at 9:24 AM
Kronos Worldwide Scales New 52-Week High on Upbeat ProspectsKronos Worldwide Scales New 52-Week High on Upbeat Prospects
www.zacks.com - November 21 at 8:36 AM
Head to Head Contrast: Ingevity Corporation (NGVT) vs. Its PeersHead to Head Contrast: Ingevity Corporation (NGVT) vs. Its Peers
www.americanbankingnews.com - November 20 at 9:12 PM
AK Steel (AKS) to Increase Price of Carbon Steel ProductsAK Steel (AKS) to Increase Price of Carbon Steel Products
www.zacks.com - November 20 at 8:02 AM
Comparing Ingevity Corporation (NGVT) & Its RivalsComparing Ingevity Corporation (NGVT) & Its Rivals
www.americanbankingnews.com - November 19 at 5:22 AM
Loop Capital Reiterates Buy Rating for Ingevity Corp (NGVT)Loop Capital Reiterates Buy Rating for Ingevity Corp (NGVT)
www.americanbankingnews.com - November 15 at 12:58 AM
Kronos Worldwide (KRO) Beats Q3 Earnings and Sales EstimatesKronos Worldwide (KRO) Beats Q3 Earnings and Sales Estimates
finance.yahoo.com - November 13 at 8:52 AM
Kronos Worldwide (KRO) Beats Q3 Earnings and Sales EstimatesKronos Worldwide (KRO) Beats Q3 Earnings and Sales Estimates
finance.yahoo.com - November 13 at 8:52 AM
Ingevitys (NGVT) CEO Michael Wilson on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaIngevity's (NGVT) CEO Michael Wilson on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 4 at 3:43 PM
Edited Transcript of NGVT earnings conference call or presentation 2-Nov-17 2:00pm GMTEdited Transcript of NGVT earnings conference call or presentation 2-Nov-17 2:00pm GMT
finance.yahoo.com - November 3 at 2:00 PM

SEC Filings

Ingevity (NYSE:NGVT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Ingevity (NYSE:NGVT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Ingevity (NYSE NGVT) Stock Chart for Saturday, December, 16, 2017

Loading chart…

This page was last updated on 12/16/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.